Dietary supplement practices in children with inherited metabolic disorders receiving protein-restricted diets
Authors:
- Bahar KuluBKBahar Kulu
- Özge Kamer Karalar PekuzÖPÖzge Kamer Karalar Pekuz
- Merve BilenMBMerve Bilen
- Duygu Uzun DinçtürkDDDuygu Uzun Dinçtürk
- Emine Didem DemirdökenEDEmine Didem Demirdöken
- Pelin Teke KısaPKPelin Teke Kısa
- Nur ArslanNANur Arslan
- 9 September 2026
- journal article
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 75
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2024
- Parental and child's psychosocial and financial burden living with an inherited metabolic disease identified by newborn screeningJournal of Inherited Metabolic Disease, 2024
- ESPEN micronutrient guidelineClinical Nutrition, 2022
- Socio-demographic factors, beliefs and health perceptions associated with use of a commercially available Ω-3 fatty acid supplement: A cross-sectional study in Asian countriesPharmaNutrition, 2020
- Determinants of taking dietary supplements in Iranian children and adolescents: the CASPIAN-V studyJournal of Diabetes & Metabolic Disorders, 2019
- Vitamin/mineral and micronutrient status in patients with classical phenylketonuriaClinical Nutrition, 2019
- Main issues in micronutrient supplementation in phenylketonuriaMolecular Genetics and Metabolism, 2013
- Nutrition in phenylketonuriaMolecular Genetics and Metabolism, 2011
- Long‐term compliance with a novel vitamin and mineral supplement in older people with PKUJournal of Inherited Metabolic Disease, 2008
- The key role of micronutrients☆Clinical Nutrition, 2006